Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MERS-CoV spike glycoprotein is an essential multifunctional envelope protein responsible for mediating virus-host cell interactions through its distinct domains. Its ability to bind human DPP4 determines infectivity and pathogenesis while also serving as a major antigenic determinant targeted by immune responses and therapeutic interventions.
Blocking receptor binding; Inhibiting membrane fusion
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein (MERS-CoV Spike).